费内伦对蛋白尿的作用 降低IgA脏病的IgA脏病
Guizhen Yu1, Meifang Wang1, Xue Zhang1
1Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Institute of Nephrology, Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Zhejiang University School of Medicine, Hangzhou, China.
Renal failure
|December 3, 2025
概括
费内伦显著降低了IgA脏病患者的蛋白尿症. 这项研究表明,finerenone可能是IgA脏病的有益治疗选择,估计质透率 (eGFR) 稳定.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 芬瑞在慢性病 (CKD) 和2型糖尿病中显示出和心血管保护作用.
- 芬在IgA脏病 (IgAN) 中的疗效尚未确定.
- 这项研究调查了finerenone在IGAN中的潜在治疗作用.
研究的目的:
- 为了评估费内伦在降低IgA脏病患者的蛋白尿的疗效.
- 为了评估费内伦对Igan患者估计的淋巴细胞过率 (eGFR) 的影响.
主要方法:
- 纳入了接受辅助治疗 (RAS阻断,血压控制,免疫抑制剂) 的18名IgA脏病患者.
- 患者接受了finerenone治疗,结果在2,4,6和8个月后进行了分析.
- 蛋白尿症 (蛋白质与肌素的比率) 和eGFR是关键的结果指标.
主要成果:
- 在2,6个月和8个月的费内伦治疗后,蛋白质与肌氨酸比率显著降低 (p <0.05).
- 蛋白尿症在2个月后降低了28.48%,在8个月后降低了39.69%.
- 在整个8个月的随访期内,估计的淋巴球过率 (eGFR) 保持稳定.
结论:
- 芬瑞治疗导致IgA脏病患者蛋白尿症显著减少.
- 费内伦对eGFR表现出稳定的作用,这表明它可能在IgAN中发挥脏保护作用.
- 费内伦可能是IgA脏病管理的新疗法.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184
Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
Factors Affecting Renal Clearance: Renal Impairment
402
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
402


